Week beginning 30th August 2021
News, articles and advocacy
UK DecodeME update
The DecodeME team has provided an update with the news that the project start date will be delayed for a few weeks in order to carry out further testing to ensure security and data protection at the study's web portal. Also included is the good news that the project has received the necessary ethics approval; and a picture of the 'spit kit' that will be sent to participants.
Thread with details
here
New Zealand
GP Dr Cathy Stephenson presented to the RNZCGP General Practice Conference on 7th August. Title: "From Harm to Help: Promoting an evidence based shift in our understanding of ME/CFS"
The slides with audio of this excellent presentation are now available.
Slides and audio
here (30 mins) Thread
here
New Zealand Dr Lynette Hodges, an Exercise Physiologist and senior lecturer at Massey University, spoke at a research seminar in Christchurch about her research into the abnormal physiological response to exercise in ME/CFS.
Video
here (35 minutes) Thread
here
IACFSME 2021 Virtual Conference Conference coverage
"Emerging data point to underlying Autoimmunity in ME/CFS" in Medscape
here
Report by dr. Sarah J. Dalziel and dr. Rosamund Vallings
here
Thread
here
USA Coverage from David Tuller and Medscape of the recently published US ME/CFS Clinician Coalition's guideline.
Trial by Error by David Tuller "While NICE Waffles, US Specialists Publish New Clinical Guidelines for ME/CFS" Article
here
Medscape "Trending Clinical Topic: Chronic Fatigue Syndrome" Article
here
Thread
here
USA - CDC
Slides and a transcript are now available from the CDC ME/CFS Stakeholder Engagement and Communication (SEC) call held on May 13, 2021. The guest speaker, Dr. Dane B. Cook, discussed results from exercise testing in the Multi-Site Clinical Assessment of ME/CFS (MCAM) study. Results showed that when ME/CFS patients and controls were matched for physical fitness, the former were breathing slower but deeper during the exercise test.
Presentation
here Slides
here Transcript
here Thread
here
Marathon Mike
Marathon Mike is running a marathon in each of the 27 EU member countries to raise awareness of ME/CFS and funds for biomedical research. This time, he interviewed two ME/CFS patients in Germany: Johanne and Claudia, ahead of his race in the Hamburg Marathon on 12 September.
Article
here Thread
here
................
UK - NICE ME/CFS Guideline
Guidelines NICE announces roundtable discussion for paused ME/CFS guideline
Short article about the planned roundtable event by NICE "to better understand the issues raised during the guidelines consultation, in accordance with issues raised during the pre-publication period of the final guideline".
Article
here Thread
here
Science for ME letter to NICE.
On 30th August the S4ME management committee sent an email urging NICE to publish the guideline without further delay and asking a series of questions including the purpose, potential outcomes and practical arrangements of the roundtable meeting. "The announcement first of the pause and then of the roundtable, and the lack of clear explanations of the purpose, agenda and next steps has caused considerable concern to our members who are relying on the new guideline to enable them to access appropriate compassionate care."
Thread with the letter
here
Trial by Error by David Tuller A Letter Urging NICE to Publish ME/CFS Guideline Without Delay
In this open letter to chief executive of NICE, Professor Gillian Leng, over 100 scientists, clinicians, academics and other experts call on NICE to publish the ME/CFS Guideline."Making changes at this late stage or cancelling publication altogether would represent a victory of vested professional interests over the rights of patients to receive care consistent with the available research."
Letter
here Thread
here
Physios for ME response to delayed NICE Guidelines
"The last minute delay to publication of the NICE Guidelines has shocked everyone involved in the process, including Physios for ME. As stakeholders we had already taken part in the lengthy and in-depth consultation process and we find it difficult to understand what more can be discussed given the finalised guidelines were based on a robust analysis of the current evidence base."
Response
here Thread
here
The Guardian "Withdrawal of planned guidance on ME upsets patients" Science correspondent Natalie Grover outlines the stated reasons for the pause in publication of the guideline, and some of the history. Grover quotes Jonathan Edwards, Michael Sharpe and others, but over emphasises the psychological versus physical, and patients versus scientist arguments.
Article
here Thread
here
Valerie Eliot Smith Legal opinion and legal advice: the "paused" NICE guidelines for "ME/CFS"
Barrister Valerie Eliot Smith's summary of the legal position surrounding the pause of the NICE guideline.
Article
here Thread
here
.................
Biomedical research
Journal of Translational Medicine
"Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms" by Nkiliza, Klimas et al
This study used lipidomic analysis on plasma from 50 each of patients and matched controls. Some sex specific differences were found, and some correlations with symptoms. The authors conclude that this 'suggests a possible role of these lipids in promoting immune dysfunction and inflammation which may be among the underlying factors driving the clinical presentation of fatigue, chronic pain, and cognitive difficulties in ill patients'.
Paper
here Thread
here
Frontiers in Systems Neuroscience
"Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Result in Sustained Improvement in ME/CFS" by Pereira, Bateman et al.
'InTiME sought to show that an
acute dose of subcutaneous CT38s in ME/CFS patients, could safely induce sustained symptom improvement..'
A small open label trial with 14 people with ME/CFS using a range of different doses found some short term changes in self reported mean daily symptom score at lower infusion levels, but decreases in measured activity levels leave interpretation of the outcomes unclear. The abstract concludes 'The trial supports the hypothesis that CRFR2 is upregulated in ME/CFS, and that acute CRFR2 agonism may be a viable treatment approach warranting further study'.
The drug company Cortene's press release describes the results as 'preliminary evidence of a cure for ME/CFS'.
Paper
here Thread
here
Journal of the American College of Cardiology
"Chronic Fatigue Syndrome and Cardiovascular Disease: JACC State-of-the-Art Review" by Natelson et al
The authors summarise research evidence showing cardiovascular findings in CFS, highlighting 'Patients with ME/CFS typically have small hearts, low stroke volume, and low total blood volume, and some have OI.' They conclude that there is a need for more studies, includinging whether deconditioning is a factor.
Article
here Thread
here
................
Other research
Health Expectations
‘A life I can cope with’. An alternative model of cognitive behavioural therapy (CBT) for CFS/ME” by Clark & Holttum
The authors conducted interviews with 13 adults who had engaged in CBT at a specialist ME/CFS service. The type of CBT aimed at improved management of the illness, rather than increasing activities and challenging unhelpful beliefs.
Article
here Thread
here
................
Coming events
UK Sussex and Kent ME/CFS Society conference in Brighton on Friday afternoon 29th October. Speakers include Dr Jessica Eccles, Dr Alan Stewart, Dr Charlotte Thompson and NHS Sussex-wide CFS/ME Service clinicians.
Thread
here
.................
Covid-19, Long Covid and ME
The Atlantic Long-Haulers are fighting for their future
In this brilliant in-depth article Ed Yong shows how academia has failed patients with ME and related conditions, and is now about to fail Long Covid patients unless the research moves forward with patients as partners.
Article
here Thread
here
The Scientist Mechanisms of Long COVID Remain Unknown but Data Are Rolling In
This article presents some current hypotheses about Long Covid and provides a global overview of some of the ongoing Long Covid studies. It also mentions that possible links between ME/CFS and Long Covid are explored.
Article
here Thread
here
New Atlas Long COVID and chronic fatigue syndrome share striking similarities
Article about the recent paper "Redox imbalance links COVID-19 and ME/CFS" from Paul, Komaroff et al. with comments from Mady Hornig who "welcomes the long-overdue attention and suggests insights gleaned from novel studies into long COVID could hopefully lead to new treatments for all kinds of post-viral illnesses".
Article
here Thread
here
The Long Haul: What Every Person Should Know About Long COVID
A recording of an August 25th webinar discussing Long COVID, moderated by Terri Wilder of #MEAction, with panelists Dr. Jennifer Curtin, Chimere Smith, and Wilhelmina Jenkins, is now available.
Video
here Thread
here
Medical Device Network "Will there ever be a test for chronic fatigue syndrome?"
About attempts of developing a biomarker for ME, and how research into Long Covid might be moving this work forward. Comments from Dr. David Strain and Dr. Charles Shepherd.
Article
here Thread
here
DW News Recovered, but still not healthy: How long COVID affects people around the world
News segment on Long Covid and ME. Professor Carmen Scheibenbogen presents three hypotheses for ME and Dr. David Strain says 1/3 long Covid patients suffers very badly. Duration 12 minutes.
YouTube video
here Thread
here
Ireland
An article in the Irish Times discusses the possible links between ME/CFS and long covid. NUI Galway-based economist Dr John Cullinan is quoted saying that the economic cost of ME/CFS in Europe is in the region of €40 billion per annum – a figure that is likely to increase as a result of Covid.
Article
here Thread
here
ABC News "What is long covid and what are the symptoms?" 8 minute interview with Dr. Richard Schloeffel who says long covid is not dissimilar to postviral syndromes and CFS.
Interview
here Thread
here
.................
S4ME social media:
Facebook,
Twitter and
You Tube